Published in Proc Natl Acad Sci U S A on March 30, 1999
A methodology for the structural and functional analysis of signaling and regulatory networks. BMC Bioinformatics (2006) 3.55
Logic-based models for the analysis of cell signaling networks. Biochemistry (2010) 2.21
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Visual setup of logical models of signaling and regulatory networks with ProMoT. BMC Bioinformatics (2006) 1.22
Mathematical modeling of intracellular signaling pathways. BMC Neurosci (2006) 1.14
Digital clocks: simple Boolean models can quantitatively describe circadian systems. J R Soc Interface (2012) 0.94
Combined logical and data-driven models for linking signalling pathways to cellular response. BMC Syst Biol (2011) 0.91
T cell activation determined by T cell receptor number and tunable thresholds. Science (1996) 5.51
Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 5.01
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 4.42
Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev (1990) 3.98
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Models of T cell anergy: is there a common molecular mechanism? J Exp Med (1996) 3.07
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol (1992) 2.39
Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science (1997) 2.33
Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 2.17
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science (1994) 2.10
Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol (1991) 2.03
T cell antigen receptor signal transduction. Curr Opin Cell Biol (1997) 1.92
T cell receptor antagonists and partial agonists. Immunity (1995) 1.83
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today (1997) 1.57
Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45
Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci U S A (1994) 1.33
Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders. Nature (1987) 1.21
Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J Immunol (1992) 1.15
Peripheral T-cell reactivity to bacterial superantigens in vivo: the response/anergy paradox. Immunol Rev (1993) 1.04
Signal transduction: clamping down on Src activity. Curr Biol (1997) 1.03
Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways. Biochem J (1997) 1.01
Induction of the increased Fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A. Eur J Immunol (1995) 1.00
Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J Biol Chem (1997) 0.98
Persistence of peptide-induced CD4+ T cell anergy in vitro. J Exp Med (1998) 0.96
Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder. Proc Natl Acad Sci U S A (1989) 0.93
Differences between responses of naive and activated T cells to anergy induction. J Immunol (1998) 0.92
Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities. J Immunol (1997) 0.92
Anergy as a mechanism of peripheral T cell tolerance. J Immunol (1996) 0.87
A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. Int Immunol (1996) 0.84
Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions. Eur J Immunol (1996) 0.84
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05
B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med (2000) 2.02
Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem (1995) 1.64
Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies. J Immunol (1985) 1.62
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol (1994) 1.58
Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits. J Exp Med (1979) 1.51
Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol (1995) 1.46
Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J Immunol (1986) 1.40
CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am J Transplant (2012) 1.36
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med (1992) 1.32
Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol (1999) 1.30
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol (1998) 1.22
Revisiting the Th1/Th2 paradigm. Scand J Immunol (1998) 1.13
Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur J Immunol (1998) 1.13
Glucocorticoids attenuate T cell receptor signaling. J Exp Med (2001) 1.10
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med (1993) 1.10
Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. J Immunol (1990) 1.06
Activation properties of T cell receptor-gamma delta hybridomas expressing diversity in both gamma- and delta-chains. J Immunol (1988) 1.03
Molecular mapping of idiotopes of anti-arsonate antibodies. J Immunol (1986) 1.02
Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation (1991) 1.01
Idiotypic analysis of polyclonal and monoclonal anti-p-azophenylarsonate antibodies of BALB/c mice expressing the major cross-reactive idiotype of the A/J strain. J Immunol (1985) 0.98
Idiotypic manipulation in mice: BALB/c mice can express the crossreactive idiotype of A/J mice. Proc Natl Acad Sci U S A (1983) 0.98
Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur J Immunol (1994) 0.97
Membrane lipid rafts: new targets for immunoregulation. Curr Mol Med (2002) 0.94
Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. Int J Cancer (1998) 0.93
Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. Transplant Proc (1990) 0.93
Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol (1996) 0.92
Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect Immun (1998) 0.91
Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs. J Clin Pathol (2000) 0.91
Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytoma. Int J Cancer (1990) 0.91
Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clin Exp Immunol (1991) 0.90
Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. J Immunol (1991) 0.89
Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions. J Immunol (1997) 0.89
FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. Int Immunol (1995) 0.89
Carbohydrate-bearing cell surface receptors involved in innate immunity: interleukin-12 induction by mitogenic and nonmitogenic lectins. Cell Immunol (1999) 0.89
Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell Immunol (1995) 0.88
B7.2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B. Eur J Immunol (1995) 0.88
Activation of murine T lymphocytes with monoclonal antibodies: detection on Lyt-2+ cells of an antigen not associated with the T cell receptor complex but involved in T cell activation. J Immunol (1987) 0.87
Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Am J Transplant (2013) 0.86
Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation. J Immunol (1999) 0.86
Idiotypic manipulation of the immune response to transplantation antigens. Immunol Rev (1986) 0.86
Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int Immunol (1995) 0.86
Role and regulation of IL-12 in the in vivo response to staphylococcal enterotoxin B. Int Immunol (1999) 0.84
Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions. Eur J Immunol (1996) 0.84
A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. Int Immunol (1996) 0.84
[Idiotypic determinants in the rabbit similar as to anti-TMV antibodies with regard to different variants of allotypic specificity a1]. Ann Immunol (Paris) (1977) 0.84
Induction of Th2 responses to soluble proteins is independent of B cell tolerance status. Int Immunol (1995) 0.83
Idiotypic games within the immune network. Immunol Rev (1986) 0.83
Study of idiotopic suppression induced by anti-cross-reactive idiotype monoclonal antibody in the anti-p-azophenylarsonate antibody response. J Immunol (1986) 0.83
Carrier-induced, hapten-specific suppression: a problem of antigen presentation? J Immunol (1998) 0.83
Idiotypes, recurrent idiotypes and internal images. Ann Immunol (Paris) (1983) 0.82
The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. Int Immunol (1998) 0.82
Idiotypic analysis of potential and available repertoires in the arsonate system. J Exp Med (1984) 0.82
Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphoma. Adv Exp Med Biol (1993) 0.81
A novel aspect of the anti-inflammatory actions of glucocorticoids: inhibition of proximal steps of signaling cascades in lymphocytes. Cell Mol Life Sci (2001) 0.81
Production and characterization of bispecific single-chain antibody fragments. Mol Immunol (1995) 0.81
The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. Int Immunol (1995) 0.80
In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model. J Immunol (1998) 0.80
CD69 is expressed on Daudi cells in response to interferon-alpha. Cytokine (1992) 0.80
Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity. Int J Cancer (1999) 0.80
Assessment of a functional role of auto-anti-idiotypes in idiotype dominance. Eur J Immunol (1995) 0.80
CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition. Immunology (1989) 0.80
Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice. Blood (1999) 0.80
Idiotypic manipulations in the arsonate system. Ann Immunol (Paris) (1984) 0.79
Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived mice. Am J Transplant (2011) 0.79
Flow cytometric measurement of calcium influx in murine T cell hybrids using Fluo-3 and an organic-anion transport inhibitor. J Immunol Methods (1994) 0.78
In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. Transplant Proc (1993) 0.78
Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma. Cancer Res (1994) 0.78
Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals. Transplant Proc (1995) 0.78
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10. Transplantation (1994) 0.78
Dendritic cells and macrophages induce the development of distinct T helper cell populations in vivo. Adv Exp Med Biol (1997) 0.78
Toxicity and neuroendocrine regulation of the immune response: a model analysis. J Theor Biol (1996) 0.77
Bispecific antibody therapy of two murine B-cell lymphomas. Int J Cancer Suppl (1992) 0.77
Dexamethasone increases intracellular cyclic AMP concentration in murine T lymphocyte cell lines. Steroids (2001) 0.77
From clonal selection to immune networks: induction of silent idiotypes. Ann N Y Acad Sci (1983) 0.77
Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3). J Immunol (1991) 0.77
Studies of the arsonate system using monoclonal antibodies. Ann N Y Acad Sci (1983) 0.77
Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. Int Immunol (1991) 0.77
T cell long-term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction. Eur J Immunol (1994) 0.76
Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody. Clin Exp Immunol (1991) 0.75
Costimulation regulates the kinetics of interleukin-2 response to bacterial superantigens. Immunology (1996) 0.75